Bachem Holding AG

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies globally. The company focuses on the development, production, and regulatory support of peptide active pharmaceutical ingredients, including peptide and oligonucleotide new chemical entities (NCEs). Bachem Holding AG also offers commercial NCEs and generics. Its services encompass project management, quality and regulatory support, analytical services, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. The company operates as a subsidiary of Ingro Finanz AG.